Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.
about
Progress and problems in understanding and managing primary Epstein-Barr virus infectionsInfectious MononucleosisSerological diagnosis of Epstein-Barr virus infection: Problems and solutionsInfectious mononucleosis.Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women.Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein-Barr virus infection.Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients.Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescFluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.Epstein-Barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence.Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.An ELISA method to compute endpoint titers to Epstein-Barr virus and cytomegalovirus: application to population-based studiesMeasurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dyeDetermination of antibody titers against soluble antigen by indirect fluorescent antibody (IFA) assay using latex particles coupled with soluble antigen: a preliminary study.An evidence-based review of peritonsillar abscess.Reliability of the Siemens Enzygnost and Novagnost Epstein-Barr virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein-Barr virus immunofluorescence assay.Possible infectious causes of spontaneous splenic rupture: a case reportA large-scale seroprevalence of Epstein-Barr virus in Taiwan.Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodiesProlonged hepatitis and jaundice: a rare complication of paediatric Epstein-Barr virus infectionNaive CD8⁺ T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamicsFrequency of Epstein - Barr Virus in Patients Presenting with Acute Febrile Illness in KenyaPerformance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.Epstein-Barr and other herpesvirus infections in patients with early onset type 1 diabetes treated with daclizumab and mycophenolate mofetilIs there diagnostic value in detection of immunoglobulin g antibodies to the epstein-barr virus early antigen?The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections.Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control?Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: a case-control study.Acute parvovirus B19 infection frequently causes false-positive results in Epstein-Barr virus- and herpes simplex virus-specific immunoglobulin M determinations done on the Liaison platform.Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patientsEvidence-based approach for interpretation of Epstein-Barr virus serological patterns.Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.Belatacept: from rational design to clinical application.Characteristics of Epstein-Barr virus hepatitis among patients with jaundice or acute hepatitis.Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.Enhancing brain lesions in a renal transplant patient.Epstein-Barr virus serology and PCR: conflicting results in an immunocompetent host. A case report and review of literature.High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious MononucleosisClinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.Epstein-Barr virus and regulatory T cells in Egyptian paediatric patients with acute B lymphoblastic leukaemia.
P2860
Q24597706-01BED330-78FC-4F39-A762-0F58CD9AE84FQ26783692-9920845D-10F2-43C7-849C-366EB5786FEAQ26829346-F7B0EFCB-34CC-42E1-882C-CB14D6C76718Q28084340-55AE68DC-B2CE-4029-8732-3D138FEEF67AQ30974379-FADF362B-3971-4246-B79A-1E96D216E98EQ33392146-5D54B5B5-7CAD-472A-AB27-7A7225939623Q33439883-2BFBB8D1-7743-4BA2-9780-50EFA01090D6Q33601876-56175788-9F93-4E56-9243-EFDAC1238D6CQ33634792-C5462A54-74FF-4EEF-A214-A93839169884Q33734608-FBD213F2-E149-4E46-8F86-ED2338FDC4D9Q33743467-47C29D99-6EC5-45C6-A149-61973A842846Q33901736-1C24C811-A1C0-4DEB-84F8-E4CEB6BD5E30Q34217149-513310CD-573E-4412-9695-E82D13990B9EQ34549644-CC3A4DCB-C238-4330-978B-BA0544163AEBQ34635768-24A587CF-C729-44CA-93F2-D43DF60F7E6CQ34753638-2D2A6440-4CE7-497F-9255-D9EFAB6255A7Q34897475-16DDA82F-EBA7-4270-8EF9-AC40186E583DQ35007123-8B6D7F42-D566-461E-BA82-22008D9EB5FCQ35591973-923797A6-4487-4B36-9F81-3B92F48EB74FQ35905044-228DF1D8-A923-406C-9BF3-6DC7AC04B4BBQ35942594-6379CEA4-7767-4F07-9E46-72E3C4AC4DBCQ36013349-E3465557-B6C1-4062-8595-31E50EFE375FQ36017708-97E6DBCB-C021-42AF-A8C4-2156B528CD90Q36477951-6603C06A-DE7D-443E-B195-717FB3A664E1Q36574561-E875F285-A8AE-4445-9A1E-C6F9E28C2945Q36687519-35F5A46F-3B86-4967-B11E-2FEE8BC5CB39Q36688962-22E0A866-4DBE-404C-B115-45F1AAB6FF61Q36888755-5AF712E9-24F4-4AA6-9ACA-A11E8ED3AD22Q37116566-C5606FEC-EA01-4D7D-988C-CA1914826419Q37213859-33BFFF14-8F96-4E3E-9B8F-08324D4E301DQ37374926-A121CD49-E9F3-4E17-9F6E-E7874A8ABD70Q37736423-E6F6490A-443F-432F-87D3-4510B562BAEFQ37965932-F7E5C2A0-7248-49F6-8D4F-9126B404B05CQ38007217-50556FB4-96D7-4CF4-AF14-78FEA962FB09Q38059610-1F7168B2-FBC3-43FF-BAC4-6576E3EFADC9Q38132156-954EC6F3-126B-48EA-835E-45A4BAB20C5EQ38219320-6A8C12C3-A11E-4AFB-899D-5BA0343B61F1Q38735147-DE159C63-5E42-48C0-AFC4-0181523D8ED4Q38794406-B2EE1310-0A11-45C7-9087-73D12BFAB68AQ38882894-7BC1F928-613A-4BB1-A2A5-43AF0EF9AB87
P2860
Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Routine Epstein-Barr virus dia ...... ll challenging after 35 years.
@ast
Routine Epstein-Barr virus dia ...... ll challenging after 35 years.
@en
type
label
Routine Epstein-Barr virus dia ...... ll challenging after 35 years.
@ast
Routine Epstein-Barr virus dia ...... ll challenging after 35 years.
@en
prefLabel
Routine Epstein-Barr virus dia ...... ll challenging after 35 years.
@ast
Routine Epstein-Barr virus dia ...... ll challenging after 35 years.
@en
P2860
P1476
Routine Epstein-Barr virus dia ...... ll challenging after 35 years.
@en
P2093
Ralf D Hess
P2860
P304
P356
10.1128/JCM.42.8.3381-3387.2004
P407
P577
2004-08-01T00:00:00Z